StockWatch
·
Pharmaceuticals
Quarterly Result3 Nov 2026, 02:31 pm

Hikal Ltd Declares Unaudited Q2 FY27 Financial Results

AI Summary

Hikal Ltd announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved the standalone and consolidated financial results, along with the cash flow statement, statement of assets and liabilities, and the limited review report from statutory auditors. The trading window for designated persons will reopen on November 06, 2026, while a special closure for directors, KMPs, and senior management will continue until further notice.

Key Highlights

  • Hikal Ltd announced unaudited financial results.
  • Results cover the quarter and half-year ended September 30, 2026.
  • Both standalone and consolidated results were approved.
  • Limited review report from statutory auditors is enclosed.
  • Trading window to reopen on November 06, 2026.